Gene Symbol | Gene ID | Gene Info |
---|---|---|
HMGA1
|
ENSG00000137309.15 | high mobility group AT-hook 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_34196829_34196980 | HMGA1 | 7746 | 0.212730 | -0.69 | 4.1e-02 | Click! |
chr6_34194457_34194608 | HMGA1 | 10118 | 0.206047 | -0.67 | 4.7e-02 | Click! |
chr6_34191430_34191685 | HMGA1 | 13093 | 0.200062 | -0.66 | 5.5e-02 | Click! |
chr6_34199985_34200136 | HMGA1 | 4590 | 0.235073 | -0.63 | 6.8e-02 | Click! |
chr6_34210568_34210962 | HMGA1 | 4197 | 0.233981 | -0.63 | 6.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_174949201_174949465 | 3.28 |
SFXN1 |
sideroflexin 1 |
43738 |
0.15 |
chr12_92579451_92579773 | 3.21 |
ENSG00000199895 |
. |
15383 |
0.19 |
chr12_9921460_9921827 | 3.04 |
CD69 |
CD69 molecule |
8146 |
0.16 |
chr15_66070362_66070791 | 2.82 |
RP11-16E23.3 |
|
10840 |
0.16 |
chr3_107799523_107799830 | 2.68 |
CD47 |
CD47 molecule |
10185 |
0.3 |
chr5_55397703_55397854 | 2.65 |
ANKRD55 |
ankyrin repeat domain 55 |
15000 |
0.17 |
chr1_65342177_65342328 | 2.60 |
JAK1 |
Janus kinase 1 |
89935 |
0.08 |
chr9_98649500_98649877 | 2.58 |
ERCC6L2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2 |
11705 |
0.19 |
chr18_3059865_3060090 | 2.58 |
ENSG00000252353 |
. |
33589 |
0.13 |
chr2_42456564_42456839 | 2.56 |
AC083949.1 |
|
59260 |
0.12 |
chr8_38665242_38665549 | 2.51 |
TACC1 |
transforming, acidic coiled-coil containing protein 1 |
2427 |
0.26 |
chr1_90078376_90078744 | 2.49 |
RP11-413E1.4 |
|
16724 |
0.16 |
chr7_12252889_12253205 | 2.49 |
TMEM106B |
transmembrane protein 106B |
2098 |
0.48 |
chr9_135224994_135225145 | 2.49 |
SETX |
senataxin |
5303 |
0.24 |
chr17_28085100_28085338 | 2.48 |
RP11-82O19.1 |
|
2902 |
0.22 |
chr1_101394971_101395556 | 2.47 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
32121 |
0.12 |
chr7_50303470_50303901 | 2.47 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
40639 |
0.19 |
chr1_209937652_209937803 | 2.46 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
4106 |
0.16 |
chr1_65342372_65342702 | 2.44 |
JAK1 |
Janus kinase 1 |
89650 |
0.08 |
chr6_41115249_41115669 | 2.44 |
TREML1 |
triggering receptor expressed on myeloid cells-like 1 |
6611 |
0.14 |
chr5_61874985_61875174 | 2.41 |
LRRC70 |
leucine rich repeat containing 70 |
377 |
0.53 |
chr7_8216722_8216994 | 2.40 |
ENSG00000265212 |
. |
22206 |
0.19 |
chr3_150921766_150922042 | 2.40 |
GPR171 |
G protein-coupled receptor 171 |
916 |
0.51 |
chr3_151965668_151966177 | 2.39 |
MBNL1 |
muscleblind-like splicing regulator 1 |
19907 |
0.21 |
chr1_167482789_167483038 | 2.35 |
CD247 |
CD247 molecule |
4862 |
0.23 |
chr16_53492869_53493169 | 2.35 |
RBL2 |
retinoblastoma-like 2 (p130) |
9031 |
0.16 |
chr10_11187947_11188252 | 2.34 |
CELF2 |
CUGBP, Elav-like family member 2 |
18894 |
0.19 |
chr1_100905257_100905795 | 2.33 |
RP5-837M10.4 |
|
46027 |
0.13 |
chr1_198657444_198657765 | 2.33 |
RP11-553K8.5 |
|
21414 |
0.23 |
chr13_42034776_42035077 | 2.32 |
RGCC |
regulator of cell cycle |
3231 |
0.2 |
chr1_169664801_169665268 | 2.29 |
SELL |
selectin L |
15805 |
0.19 |
chr1_89724216_89724367 | 2.28 |
RP4-620F22.2 |
|
1974 |
0.32 |
chrX_19770106_19770364 | 2.28 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
4414 |
0.34 |
chr17_28031238_28031461 | 2.27 |
RP11-82O19.1 |
|
56772 |
0.07 |
chr14_98100754_98101076 | 2.26 |
ENSG00000240730 |
. |
104405 |
0.08 |
chr12_9807704_9808028 | 2.25 |
RP11-705C15.2 |
|
1587 |
0.25 |
chr11_128162482_128162771 | 2.24 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
212663 |
0.02 |
chr3_112192770_112193234 | 2.23 |
BTLA |
B and T lymphocyte associated |
25203 |
0.21 |
chr3_69145351_69145608 | 2.23 |
ARL6IP5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
11307 |
0.14 |
chr22_40730411_40730669 | 2.22 |
ADSL |
adenylosuccinate lyase |
11967 |
0.19 |
chr2_102332100_102332251 | 2.21 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
17183 |
0.28 |
chr10_69371869_69372293 | 2.20 |
CTNNA3 |
catenin (cadherin-associated protein), alpha 3 |
35190 |
0.23 |
chr9_92031645_92032185 | 2.19 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
1833 |
0.43 |
chr6_36067372_36067741 | 2.19 |
MAPK13 |
mitogen-activated protein kinase 13 |
30542 |
0.14 |
chr1_84613467_84613691 | 2.18 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
3625 |
0.34 |
chr3_151965153_151965304 | 2.16 |
MBNL1 |
muscleblind-like splicing regulator 1 |
20601 |
0.21 |
chr21_19155131_19155430 | 2.16 |
AL109761.5 |
|
10525 |
0.23 |
chr16_79306408_79306967 | 2.15 |
ENSG00000222244 |
. |
8336 |
0.31 |
chr6_154569291_154569730 | 2.15 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
694 |
0.82 |
chr17_39494552_39494703 | 2.15 |
KRT33A |
keratin 33A |
12437 |
0.08 |
chr1_117305177_117305379 | 2.15 |
CD2 |
CD2 molecule |
8189 |
0.23 |
chr10_125001475_125001893 | 2.13 |
ENSG00000265463 |
. |
25980 |
0.21 |
chr6_143849877_143850466 | 2.12 |
PHACTR2 |
phosphatase and actin regulator 2 |
7811 |
0.16 |
chr1_100855689_100855863 | 2.12 |
ENSG00000216067 |
. |
11445 |
0.2 |
chr4_109081453_109081912 | 2.11 |
LEF1 |
lymphoid enhancer-binding factor 1 |
5775 |
0.24 |
chr2_144012089_144012556 | 2.10 |
RP11-190J23.1 |
|
82581 |
0.1 |
chr16_25071874_25072133 | 2.10 |
ARHGAP17 |
Rho GTPase activating protein 17 |
45016 |
0.14 |
chr5_130710929_130711409 | 2.10 |
CDC42SE2 |
CDC42 small effector 2 |
10130 |
0.3 |
chr3_71537410_71537957 | 2.10 |
ENSG00000221264 |
. |
53557 |
0.14 |
chr6_154571557_154571984 | 2.10 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
2954 |
0.4 |
chr3_18431741_18431970 | 2.09 |
RP11-158G18.1 |
|
19272 |
0.22 |
chr19_48751262_48751530 | 2.09 |
CARD8 |
caspase recruitment domain family, member 8 |
1529 |
0.27 |
chr9_95473711_95474015 | 2.09 |
IPPK |
inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
41316 |
0.14 |
chr4_164587902_164588286 | 2.07 |
MARCH1 |
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
53408 |
0.16 |
chr10_31081414_31081648 | 2.07 |
RP11-330O11.3 |
|
40785 |
0.17 |
chr17_43228041_43228343 | 2.06 |
HEXIM1 |
hexamethylene bis-acetamide inducible 1 |
3508 |
0.12 |
chr9_31336363_31336898 | 2.06 |
ENSG00000211510 |
. |
562404 |
0.0 |
chr10_6056816_6057012 | 2.06 |
ENSG00000251922 |
. |
2243 |
0.23 |
chr4_103510077_103510373 | 2.05 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
11204 |
0.22 |
chr10_33408293_33408482 | 2.04 |
ENSG00000263576 |
. |
20823 |
0.22 |
chr8_42567470_42567887 | 2.04 |
RP11-412B14.1 |
|
9411 |
0.19 |
chr11_5246485_5246763 | 2.03 |
ENSG00000221031 |
. |
755 |
0.38 |
chr3_18477634_18477910 | 2.03 |
SATB1 |
SATB homeobox 1 |
1027 |
0.57 |
chr6_24958590_24958741 | 2.02 |
FAM65B |
family with sequence similarity 65, member B |
22477 |
0.2 |
chr3_113941510_113941806 | 2.02 |
RP11-553L6.2 |
|
8420 |
0.17 |
chr6_119166791_119167037 | 2.02 |
MCM9 |
minichromosome maintenance complex component 9 |
16498 |
0.22 |
chr13_41188048_41188199 | 2.02 |
FOXO1 |
forkhead box O1 |
52611 |
0.14 |
chr10_65033826_65034075 | 2.02 |
JMJD1C |
jumonji domain containing 1C |
4968 |
0.31 |
chr3_141216828_141216979 | 2.00 |
RASA2 |
RAS p21 protein activator 2 |
11012 |
0.22 |
chr15_38942394_38942965 | 2.00 |
C15orf53 |
chromosome 15 open reading frame 53 |
46120 |
0.16 |
chr3_105474696_105474847 | 2.00 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
53726 |
0.18 |
chr7_37355725_37356299 | 1.99 |
ELMO1 |
engulfment and cell motility 1 |
26355 |
0.19 |
chr4_78707927_78708078 | 1.99 |
CNOT6L |
CCR4-NOT transcription complex, subunit 6-like |
32215 |
0.21 |
chr17_40425327_40425695 | 1.99 |
AC003104.1 |
|
810 |
0.47 |
chr5_66512764_66513039 | 1.98 |
CD180 |
CD180 molecule |
20274 |
0.26 |
chr16_15732426_15732695 | 1.97 |
KIAA0430 |
KIAA0430 |
3785 |
0.16 |
chr1_24854438_24854691 | 1.96 |
ENSG00000266551 |
. |
1640 |
0.34 |
chr4_78737547_78737811 | 1.96 |
CNOT6L |
CCR4-NOT transcription complex, subunit 6-like |
2538 |
0.37 |
chr6_166831574_166831950 | 1.95 |
RP1-168L15.5 |
|
35085 |
0.13 |
chr7_50355378_50355619 | 1.95 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
7180 |
0.3 |
chr2_74280337_74280866 | 1.94 |
TET3 |
tet methylcytosine dioxygenase 3 |
7151 |
0.19 |
chr4_40249519_40249765 | 1.94 |
RHOH |
ras homolog family member H |
47678 |
0.14 |
chr4_109042551_109042934 | 1.94 |
LEF1 |
lymphoid enhancer-binding factor 1 |
44715 |
0.15 |
chr2_191873464_191873773 | 1.94 |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
4695 |
0.2 |
chr3_170970182_170970459 | 1.93 |
TNIK |
TRAF2 and NCK interacting kinase |
26820 |
0.24 |
chr2_36473322_36473473 | 1.93 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
109672 |
0.07 |
chr10_22941373_22941792 | 1.93 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
60940 |
0.14 |
chr13_46750553_46750948 | 1.93 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
5709 |
0.17 |
chr12_25206315_25206466 | 1.92 |
LRMP |
lymphoid-restricted membrane protein |
716 |
0.7 |
chr11_128568487_128568763 | 1.92 |
SENCR |
smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA |
2707 |
0.25 |
chr10_30790292_30790443 | 1.92 |
ENSG00000239744 |
. |
54466 |
0.13 |
chr5_39161384_39161535 | 1.92 |
FYB |
FYN binding protein |
41670 |
0.17 |
chr3_33084378_33084559 | 1.92 |
GLB1 |
galactosidase, beta 1 |
53816 |
0.11 |
chr10_26739182_26739333 | 1.91 |
APBB1IP |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
11903 |
0.27 |
chr3_112183882_112184126 | 1.90 |
BTLA |
B and T lymphocyte associated |
34201 |
0.19 |
chr8_41876657_41876808 | 1.90 |
ENSG00000238966 |
. |
24361 |
0.18 |
chr4_102249058_102249209 | 1.90 |
ENSG00000221265 |
. |
2438 |
0.3 |
chr2_203515077_203515228 | 1.89 |
FAM117B |
family with sequence similarity 117, member B |
15241 |
0.27 |
chr2_197019655_197020043 | 1.89 |
STK17B |
serine/threonine kinase 17b |
1522 |
0.4 |
chr15_60850795_60851057 | 1.88 |
CTD-2501E16.2 |
|
28754 |
0.16 |
chr5_100224229_100224437 | 1.88 |
ST8SIA4 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
14585 |
0.28 |
chr2_143912301_143912573 | 1.88 |
RP11-190J23.1 |
|
17304 |
0.23 |
chr16_53497805_53498195 | 1.87 |
RBL2 |
retinoblastoma-like 2 (p130) |
14012 |
0.15 |
chr2_144990435_144990671 | 1.86 |
GTDC1 |
glycosyltransferase-like domain containing 1 |
2751 |
0.42 |
chr4_164513114_164513376 | 1.85 |
MARCH1 |
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
21441 |
0.23 |
chr20_43996735_43996900 | 1.85 |
SYS1 |
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae) |
4723 |
0.13 |
chr12_40023753_40023976 | 1.85 |
C12orf40 |
chromosome 12 open reading frame 40 |
3879 |
0.28 |
chr17_33546311_33546587 | 1.85 |
RP11-799D4.4 |
|
18551 |
0.12 |
chr6_158305191_158305342 | 1.84 |
RP3-403L10.3 |
|
8552 |
0.17 |
chr1_198623376_198623667 | 1.84 |
RP11-553K8.5 |
|
12669 |
0.23 |
chr3_71352722_71352944 | 1.84 |
FOXP1 |
forkhead box P1 |
1078 |
0.61 |
chr4_102248571_102248968 | 1.83 |
ENSG00000221265 |
. |
2802 |
0.28 |
chr8_2080105_2080333 | 1.83 |
MYOM2 |
myomesin 2 |
87035 |
0.1 |
chr14_36788692_36788999 | 1.83 |
MBIP |
MAP3K12 binding inhibitory protein 1 |
231 |
0.94 |
chr3_46330793_46330944 | 1.83 |
CCR3 |
chemokine (C-C motif) receptor 3 |
24249 |
0.18 |
chr2_198114230_198114393 | 1.82 |
ANKRD44 |
ankyrin repeat domain 44 |
51549 |
0.11 |
chr3_108540551_108540702 | 1.82 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
919 |
0.68 |
chr9_129231460_129231761 | 1.82 |
ENSG00000252985 |
. |
42438 |
0.14 |
chr5_39189552_39189909 | 1.81 |
FYB |
FYN binding protein |
13399 |
0.27 |
chr4_123355382_123355533 | 1.81 |
IL2 |
interleukin 2 |
22423 |
0.22 |
chr5_7778754_7778905 | 1.81 |
RP11-711G10.1 |
|
28950 |
0.2 |
chr7_50362141_50362349 | 1.81 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
5000 |
0.32 |
chrX_135710701_135710975 | 1.81 |
ENSG00000233093 |
. |
10864 |
0.16 |
chr3_108541126_108541349 | 1.80 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
308 |
0.93 |
chr18_56361181_56361418 | 1.80 |
RP11-126O1.4 |
|
16453 |
0.15 |
chr1_211526157_211526486 | 1.80 |
TRAF5 |
TNF receptor-associated factor 5 |
6615 |
0.27 |
chr3_186723502_186723653 | 1.79 |
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
16066 |
0.22 |
chr18_2963293_2963716 | 1.79 |
RP11-737O24.1 |
|
3512 |
0.19 |
chr12_21832380_21832693 | 1.79 |
RP11-59N23.3 |
|
17289 |
0.18 |
chr1_111437821_111438265 | 1.78 |
CD53 |
CD53 molecule |
22267 |
0.15 |
chr12_46285383_46285564 | 1.78 |
ENSG00000265093 |
. |
17661 |
0.21 |
chr1_198600457_198600813 | 1.78 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
7166 |
0.26 |
chr17_33858933_33859180 | 1.78 |
SLFN12L |
schlafen family member 12-like |
5824 |
0.12 |
chr5_56137680_56137933 | 1.77 |
ENSG00000238717 |
. |
15169 |
0.15 |
chr2_191380853_191381289 | 1.77 |
TMEM194B |
transmembrane protein 194B |
18012 |
0.15 |
chr12_66685588_66685946 | 1.77 |
ENSG00000222744 |
. |
696 |
0.65 |
chr22_27072797_27072948 | 1.76 |
CRYBA4 |
crystallin, beta A4 |
54944 |
0.12 |
chr12_62706936_62707193 | 1.76 |
USP15 |
ubiquitin specific peptidase 15 |
7688 |
0.22 |
chr2_197064930_197065081 | 1.76 |
ENSG00000239161 |
. |
15041 |
0.18 |
chr17_34906652_34907000 | 1.76 |
GGNBP2 |
gametogenetin binding protein 2 |
5473 |
0.14 |
chr5_67534562_67534771 | 1.76 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
1060 |
0.63 |
chr18_29623121_29623509 | 1.76 |
ENSG00000265063 |
. |
17637 |
0.13 |
chr5_39211100_39211451 | 1.76 |
FYB |
FYN binding protein |
8146 |
0.29 |
chr17_37929536_37929825 | 1.75 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
4798 |
0.15 |
chr1_235484471_235484652 | 1.75 |
GGPS1 |
geranylgeranyl diphosphate synthase 1 |
6104 |
0.2 |
chr1_112168660_112168811 | 1.75 |
RAP1A |
RAP1A, member of RAS oncogene family |
5966 |
0.19 |
chr1_168489063_168489385 | 1.75 |
XCL2 |
chemokine (C motif) ligand 2 |
24011 |
0.22 |
chr18_2607304_2607591 | 1.74 |
NDC80 |
NDC80 kinetochore complex component |
3333 |
0.18 |
chr1_101397245_101397396 | 1.74 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
30064 |
0.13 |
chr7_142408502_142408658 | 1.74 |
MTRNR2L6 |
MT-RNR2-like 6 |
34476 |
0.16 |
chr16_17546246_17546397 | 1.74 |
XYLT1 |
xylosyltransferase I |
18417 |
0.3 |
chr1_12405936_12406365 | 1.73 |
VPS13D |
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
63774 |
0.11 |
chr15_75897999_75898196 | 1.73 |
SNUPN |
snurportin 1 |
11768 |
0.11 |
chr1_14059116_14059267 | 1.71 |
PRDM2 |
PR domain containing 2, with ZNF domain |
16707 |
0.21 |
chr14_52360876_52361221 | 1.71 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
16738 |
0.17 |
chr4_15019168_15019379 | 1.71 |
CPEB2 |
cytoplasmic polyadenylation element binding protein 2 |
13713 |
0.28 |
chr17_62966354_62966778 | 1.71 |
AMZ2P1 |
archaelysin family metallopeptidase 2 pseudogene 1 |
3069 |
0.2 |
chr2_198056102_198056290 | 1.71 |
ANKRD44 |
ankyrin repeat domain 44 |
4363 |
0.24 |
chr8_61706063_61706431 | 1.71 |
RP11-33I11.2 |
|
15918 |
0.26 |
chr4_84131828_84132015 | 1.71 |
PLAC8 |
placenta-specific 8 |
73693 |
0.1 |
chr22_32521664_32521815 | 1.70 |
RP1-127L4.10 |
|
3937 |
0.18 |
chr3_43344540_43344763 | 1.70 |
ENSG00000241939 |
. |
11792 |
0.17 |
chrX_78431490_78431736 | 1.70 |
GPR174 |
G protein-coupled receptor 174 |
5144 |
0.35 |
chr11_65869163_65869474 | 1.70 |
PACS1 |
phosphofurin acidic cluster sorting protein 1 |
1084 |
0.36 |
chr1_84947405_84947599 | 1.70 |
RPF1 |
ribosome production factor 1 homolog (S. cerevisiae) |
2552 |
0.27 |
chr10_22899839_22899998 | 1.70 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
19276 |
0.27 |
chrX_19770837_19771004 | 1.69 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
5099 |
0.33 |
chr1_100906460_100907038 | 1.69 |
RP5-837M10.4 |
|
44804 |
0.14 |
chr3_4892401_4892676 | 1.69 |
ENSG00000239126 |
. |
27848 |
0.18 |
chr5_130706488_130706854 | 1.69 |
CDC42SE2 |
CDC42 small effector 2 |
14628 |
0.29 |
chrX_65086861_65087012 | 1.68 |
RP6-159A1.3 |
|
132657 |
0.05 |
chr6_152504784_152505178 | 1.68 |
SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
15482 |
0.29 |
chrX_77035225_77035610 | 1.68 |
ATRX |
alpha thalassemia/mental retardation syndrome X-linked |
6285 |
0.26 |
chr1_198529109_198529554 | 1.68 |
ATP6V1G3 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 |
19256 |
0.26 |
chr14_51279547_51280135 | 1.68 |
RP11-286O18.1 |
|
8757 |
0.15 |
chr8_38225741_38225946 | 1.68 |
WHSC1L1 |
Wolf-Hirschhorn syndrome candidate 1-like 1 |
12496 |
0.12 |
chr7_50416954_50417168 | 1.68 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
49816 |
0.15 |
chr13_109061568_109062120 | 1.68 |
ENSG00000223177 |
. |
108165 |
0.07 |
chr5_156606721_156606948 | 1.67 |
ITK |
IL2-inducible T-cell kinase |
1003 |
0.44 |
chr18_68325878_68326137 | 1.67 |
GTSCR1 |
Gilles de la Tourette syndrome chromosome region, candidate 1 |
8027 |
0.32 |
chr12_68176752_68176973 | 1.67 |
RP11-335O4.3 |
|
112163 |
0.07 |
chr1_198605564_198605715 | 1.67 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
2162 |
0.39 |
chr16_79305361_79305684 | 1.67 |
ENSG00000222244 |
. |
7171 |
0.31 |
chr2_99375995_99376391 | 1.67 |
ENSG00000201070 |
. |
22680 |
0.19 |
chr11_128171276_128171427 | 1.66 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
203938 |
0.03 |
chr14_99725088_99725556 | 1.66 |
AL109767.1 |
|
3963 |
0.26 |
chr2_61113959_61114402 | 1.66 |
REL |
v-rel avian reticuloendotheliosis viral oncogene homolog |
5389 |
0.21 |
chr17_1775725_1776037 | 1.66 |
RPA1 |
replication protein A1, 70kDa |
6448 |
0.16 |
chr8_42563987_42564274 | 1.66 |
CHRNB3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
11568 |
0.18 |
chr10_124170456_124170607 | 1.66 |
ENSG00000265442 |
. |
5950 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 22.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
3.6 | 14.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
3.4 | 3.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
3.0 | 9.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
3.0 | 11.9 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
2.8 | 11.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
2.4 | 4.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
2.4 | 7.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
2.4 | 9.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.3 | 9.4 | GO:0002664 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
2.3 | 6.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.2 | 6.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.1 | 2.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
2.0 | 14.3 | GO:0007172 | signal complex assembly(GO:0007172) |
2.0 | 6.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
1.9 | 15.5 | GO:0006491 | N-glycan processing(GO:0006491) |
1.9 | 5.7 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
1.9 | 5.7 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.8 | 8.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.5 | 10.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
1.4 | 4.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
1.4 | 7.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
1.4 | 7.0 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
1.3 | 6.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.3 | 4.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.3 | 4.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.3 | 4.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.3 | 4.0 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
1.3 | 5.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.3 | 5.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
1.3 | 2.6 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
1.3 | 2.5 | GO:0002507 | tolerance induction(GO:0002507) |
1.3 | 1.3 | GO:0002335 | mature B cell differentiation(GO:0002335) |
1.2 | 6.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.2 | 2.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.2 | 9.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.2 | 3.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.2 | 3.6 | GO:0072033 | renal vesicle formation(GO:0072033) |
1.2 | 9.7 | GO:0002836 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
1.2 | 3.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
1.2 | 4.8 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
1.2 | 10.7 | GO:0043368 | positive T cell selection(GO:0043368) |
1.2 | 10.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
1.2 | 2.3 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
1.2 | 1.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
1.1 | 3.4 | GO:0051665 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
1.1 | 4.5 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
1.1 | 9.0 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.1 | 3.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
1.1 | 11.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.1 | 28.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
1.0 | 3.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.0 | 3.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
1.0 | 2.0 | GO:0001821 | histamine secretion(GO:0001821) |
1.0 | 1.0 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
1.0 | 2.9 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
1.0 | 1.9 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
1.0 | 1.9 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
1.0 | 1.9 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.9 | 4.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.9 | 9.0 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.9 | 1.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.9 | 6.3 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.9 | 7.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 5.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.9 | 1.8 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.9 | 1.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.9 | 0.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.9 | 4.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.9 | 3.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.9 | 5.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.9 | 3.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.8 | 0.8 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.8 | 4.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.8 | 2.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.8 | 5.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.8 | 1.6 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.8 | 4.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.8 | 2.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.8 | 3.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.8 | 2.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.8 | 14.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.8 | 2.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.8 | 2.3 | GO:0045056 | transcytosis(GO:0045056) |
0.8 | 1.6 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.8 | 2.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.8 | 2.3 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.8 | 0.8 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.8 | 2.3 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.8 | 1.5 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.7 | 1.5 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.7 | 0.7 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.7 | 7.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.7 | 2.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.7 | 2.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.7 | 2.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.7 | 2.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.7 | 10.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.7 | 2.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.7 | 7.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.7 | 3.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.7 | 37.2 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.7 | 1.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.7 | 2.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.7 | 2.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.7 | 2.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.7 | 2.6 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.7 | 0.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.7 | 2.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.7 | 1.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.7 | 3.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.7 | 2.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.6 | 5.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.6 | 2.5 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.6 | 1.2 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.6 | 2.5 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.6 | 1.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.6 | 1.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 1.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 1.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.6 | 0.6 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.6 | 2.9 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.6 | 5.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.6 | 1.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 2.9 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.6 | 1.8 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.6 | 3.5 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.6 | 0.6 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.6 | 1.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.6 | 2.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.6 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 1.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.6 | 2.3 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.6 | 5.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.6 | 1.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.6 | 1.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.6 | 0.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.6 | 2.8 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.5 | 1.1 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.5 | 2.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.5 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.5 | 1.6 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.5 | 0.5 | GO:0035304 | regulation of protein dephosphorylation(GO:0035304) |
0.5 | 1.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.5 | 5.4 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.5 | 12.3 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.5 | 0.5 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 12.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.5 | 2.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 5.7 | GO:0000303 | response to superoxide(GO:0000303) |
0.5 | 1.0 | GO:0033622 | integrin activation(GO:0033622) |
0.5 | 2.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.5 | 4.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 1.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.5 | 4.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.5 | 1.0 | GO:0034776 | response to histamine(GO:0034776) |
0.5 | 2.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.5 | 4.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.5 | 1.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.5 | 1.5 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.5 | 2.4 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.5 | 1.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.5 | 1.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.5 | 12.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.5 | 1.0 | GO:0097553 | sequestering of calcium ion(GO:0051208) release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
0.5 | 1.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.5 | 1.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.5 | 1.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.5 | 1.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.5 | 4.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.5 | 3.3 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.5 | 1.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 3.2 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.5 | 0.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.5 | 1.8 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.5 | 2.8 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.5 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 3.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.5 | 0.9 | GO:0016556 | mRNA modification(GO:0016556) |
0.5 | 1.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.5 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 2.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 0.9 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.4 | 1.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.4 | 5.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 2.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.4 | 3.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 4.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 1.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 0.4 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.4 | 3.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.4 | 1.3 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.4 | 2.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.4 | 1.3 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.4 | 1.3 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.4 | 1.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.4 | 3.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.4 | 2.1 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.4 | 0.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 0.4 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 1.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.4 | 1.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 1.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 0.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.4 | 1.2 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.4 | 1.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 6.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 0.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 0.4 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.4 | 0.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 1.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 1.6 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 9.1 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.4 | 1.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 0.8 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.4 | 2.0 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.4 | 6.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.4 | 1.2 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 0.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.4 | 1.9 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 0.8 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 9.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.4 | 1.5 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.4 | 1.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 4.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.4 | 2.3 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.4 | 2.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 1.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 3.0 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 1.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 0.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.4 | 0.7 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.4 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 2.2 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.4 | 1.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 4.0 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.4 | 1.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.4 | 0.4 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.4 | 1.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.4 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.4 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
0.4 | 2.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.4 | 1.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 1.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.4 | 0.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 0.4 | GO:0071803 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.3 | 1.7 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.3 | 0.3 | GO:0042991 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.3 | 0.3 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.3 | 1.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 2.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 2.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 0.7 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.3 | 1.7 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 1.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 4.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.3 | GO:0070265 | necrotic cell death(GO:0070265) |
0.3 | 1.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 0.7 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.3 | 1.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 1.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.3 | 1.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 4.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 1.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 0.6 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.3 | 1.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 1.0 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.3 | 1.9 | GO:0042098 | T cell proliferation(GO:0042098) |
0.3 | 1.0 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 0.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 0.6 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 1.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 0.3 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.3 | 0.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 6.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 0.6 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 0.6 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 0.9 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.3 | 0.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.6 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 1.6 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.3 | 0.3 | GO:0002883 | hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) |
0.3 | 1.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 0.6 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.3 | 3.4 | GO:0001510 | RNA methylation(GO:0001510) |
0.3 | 1.5 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.3 | 1.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.3 | 3.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 17.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.3 | 0.3 | GO:0051138 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.3 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.3 | 7.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.3 | 3.9 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.3 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 24.0 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 2.1 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.3 | 1.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 3.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 5.3 | GO:0006997 | nucleus organization(GO:0006997) |
0.3 | 0.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 1.2 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.3 | 0.6 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.3 | 1.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 0.6 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.3 | 1.8 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.3 | 2.3 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 0.3 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.3 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 0.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 0.6 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.3 | 0.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 0.3 | GO:0001832 | blastocyst growth(GO:0001832) |
0.3 | 0.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.6 | GO:0032418 | lysosome localization(GO:0032418) |
0.3 | 2.3 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.3 | 1.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 1.4 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.3 | 6.7 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.3 | 0.8 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.3 | 1.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 1.4 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.3 | 2.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.3 | 2.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 1.1 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.3 | 0.3 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.3 | 14.8 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 1.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 0.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 0.8 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.3 | 0.5 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.3 | 4.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.3 | 2.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.3 | 0.5 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.3 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 1.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.3 | 0.8 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.3 | 2.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.3 | 1.6 | GO:1904377 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.3 | 1.6 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.3 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.3 | 1.3 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.3 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.3 | 0.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 2.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 0.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 37.4 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.3 | 1.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.3 | 2.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 0.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.3 | 0.5 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 0.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 1.3 | GO:0051806 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.3 | 2.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 12.6 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 12.3 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.3 | 1.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.3 | 2.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.5 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.2 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 4.0 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.2 | 0.5 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.7 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 2.7 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.2 | 5.9 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.2 | 0.2 | GO:0051970 | regulation of transmission of nerve impulse(GO:0051969) negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.7 | GO:0016233 | telomere capping(GO:0016233) |
0.2 | 1.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 0.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) telomere formation via telomerase(GO:0032203) |
0.2 | 2.7 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.2 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
0.2 | 2.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 5.9 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 0.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 4.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 1.2 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.2 | 0.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.5 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.2 | 0.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 4.4 | GO:0016571 | histone methylation(GO:0016571) |
0.2 | 3.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.2 | GO:0032649 | interferon-gamma production(GO:0032609) regulation of interferon-gamma production(GO:0032649) |
0.2 | 9.9 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.2 | 1.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.7 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 0.2 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.2 | 1.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.2 | 0.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.4 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 0.4 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.2 | 0.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.2 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
0.2 | 5.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 3.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 1.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.2 | GO:1901890 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.2 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.7 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 1.1 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 1.3 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.2 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 1.1 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 1.3 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.2 | 6.2 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 0.2 | GO:1903578 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.2 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 1.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 0.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.2 | 4.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 7.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.4 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.2 | 0.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.6 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 1.4 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 1.7 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 0.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 24.2 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 0.2 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.2 | 0.6 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.8 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 1.8 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.4 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 1.4 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 0.6 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.2 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 3.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 1.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 1.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.2 | 1.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 0.4 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 1.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 0.6 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.2 | 2.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 5.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 21.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.2 | 0.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 1.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.2 | 3.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 1.2 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 1.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 0.6 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 0.8 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.2 | 0.2 | GO:0035987 | endodermal cell fate commitment(GO:0001711) endodermal cell differentiation(GO:0035987) |
0.2 | 0.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 2.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.4 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.2 | 4.0 | GO:0021549 | cerebellum development(GO:0021549) |
0.2 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.9 | GO:0098930 | axonal transport(GO:0098930) |
0.2 | 1.1 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.2 | 0.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 2.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 0.4 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.2 | 0.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.2 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 3.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 0.2 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 0.9 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 1.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.2 | 0.9 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.2 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.2 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.2 | 0.4 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.2 | 0.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 1.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.9 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 2.0 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 0.4 | GO:0007320 | insemination(GO:0007320) |
0.2 | 0.4 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.2 | 1.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 2.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.7 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.2 | 0.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.4 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.2 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.2 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 1.4 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.2 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 0.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 1.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 1.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.7 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.2 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 5.6 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.2 | 0.2 | GO:0034644 | cellular response to UV(GO:0034644) |
0.2 | 3.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 1.5 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.2 | 0.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.3 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 5.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.2 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 2.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.2 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 1.1 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 0.2 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.8 | GO:1903523 | negative regulation of blood circulation(GO:1903523) |
0.2 | 2.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.2 | 0.3 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.2 | 0.5 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.2 | 0.6 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 0.2 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.2 | 0.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.2 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.2 | 3.7 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.2 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.2 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 1.8 | GO:0051607 | defense response to virus(GO:0051607) |
0.2 | 0.5 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.2 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.5 | GO:0015853 | adenine transport(GO:0015853) |
0.2 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.6 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.2 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 1.0 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 1.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 1.0 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.4 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.1 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.3 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.1 | 0.4 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.3 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 2.6 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 2.6 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.7 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.1 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 2.9 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.8 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:0072205 | collecting duct development(GO:0072044) metanephric collecting duct development(GO:0072205) |
0.1 | 1.8 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.1 | 0.8 | GO:0042572 | primary alcohol metabolic process(GO:0034308) retinol metabolic process(GO:0042572) |
0.1 | 2.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 2.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 2.8 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.3 | GO:0072176 | nephric duct development(GO:0072176) |
0.1 | 0.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 1.1 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.1 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.1 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.1 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.4 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 1.2 | GO:0051899 | membrane depolarization(GO:0051899) |
0.1 | 0.1 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.1 | 0.3 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 6.4 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 1.0 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 1.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 2.9 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.1 | 0.3 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.2 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0036314 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.1 | 0.7 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 2.7 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.1 | 0.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 2.5 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.2 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 34.6 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 1.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 1.0 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 1.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 1.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.2 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 1.0 | GO:0048925 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.1 | 2.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.2 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.1 | 0.7 | GO:0009068 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 0.4 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.4 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.4 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.9 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 3.5 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.2 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.5 | GO:0046036 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 0.8 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.1 | 0.6 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 12.3 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 2.1 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.2 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 0.3 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.1 | 0.3 | GO:0048857 | neural nucleus development(GO:0048857) |
0.1 | 1.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.6 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 1.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 0.2 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 0.1 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 1.1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.6 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 8.3 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.1 | 0.2 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.8 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.3 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.1 | 2.1 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.3 | GO:0042596 | fear response(GO:0042596) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 0.2 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.5 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.2 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.5 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.2 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.1 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 6.9 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.7 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.2 | GO:0021545 | cranial nerve development(GO:0021545) |
0.1 | 0.7 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 1.1 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 1.7 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.1 | 0.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.3 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 2.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.7 | GO:0071902 | positive regulation of protein serine/threonine kinase activity(GO:0071902) |
0.1 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.1 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.1 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.2 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) positive regulation of neuron death(GO:1901216) |
0.1 | 0.1 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 3.9 | GO:0006323 | DNA packaging(GO:0006323) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.1 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.1 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.7 | GO:0055067 | monovalent inorganic cation homeostasis(GO:0055067) |
0.1 | 0.6 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 20.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 1.0 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.2 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0071331 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.0 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.3 | GO:0042430 | indole-containing compound metabolic process(GO:0042430) |
0.0 | 0.1 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.7 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.0 | 0.7 | GO:0019400 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.0 | 1.7 | GO:0034440 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.0 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.4 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.2 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.4 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.0 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.0 | 0.3 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.5 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.2 | GO:0032606 | type I interferon production(GO:0032606) |
0.0 | 0.0 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.2 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.9 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.2 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.4 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.1 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 1.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.0 | GO:0071103 | DNA conformation change(GO:0071103) |
0.0 | 0.6 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.0 | 0.3 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.0 | 0.1 | GO:0072665 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.1 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
0.0 | 0.1 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.9 | GO:0070252 | actin-mediated cell contraction(GO:0070252) |
0.0 | 0.5 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.8 | GO:0009135 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.0 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 1.0 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.8 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.0 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.0 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.0 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.0 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.0 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.0 | 0.0 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0051657 | regulation of asymmetric cell division(GO:0009786) maintenance of organelle location(GO:0051657) |
0.0 | 0.0 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.0 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.0 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.0 | 0.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.0 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.8 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.3 | GO:0007588 | excretion(GO:0007588) |
0.0 | 1.8 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:2000757 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.0 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 7.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.3 | 18.4 | GO:0001891 | phagocytic cup(GO:0001891) |
1.4 | 4.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.4 | 4.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.3 | 2.6 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
1.3 | 5.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.3 | 15.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.2 | 3.5 | GO:0072487 | MSL complex(GO:0072487) |
1.2 | 6.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.1 | 1.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.0 | 9.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.0 | 14.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.0 | 4.1 | GO:0005827 | polar microtubule(GO:0005827) |
1.0 | 11.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.9 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.9 | 2.7 | GO:0071942 | XPC complex(GO:0071942) |
0.9 | 2.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 4.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.8 | 4.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.8 | 3.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.8 | 2.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.8 | 11.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.7 | 7.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 0.7 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.7 | 2.9 | GO:0043218 | compact myelin(GO:0043218) |
0.7 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 3.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.7 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 2.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.7 | 3.3 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 4.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 2.0 | GO:0016528 | sarcoplasm(GO:0016528) sarcoplasmic reticulum(GO:0016529) |
0.7 | 4.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.6 | 1.9 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.6 | 6.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.6 | 1.2 | GO:0032449 | CBM complex(GO:0032449) |
0.6 | 3.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 1.8 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.6 | 6.5 | GO:0045120 | pronucleus(GO:0045120) |
0.6 | 0.6 | GO:0042827 | platelet dense granule(GO:0042827) |
0.6 | 9.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.6 | 19.9 | GO:0030175 | filopodium(GO:0030175) |
0.6 | 5.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.6 | 1.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.6 | 1.1 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.5 | 1.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 2.1 | GO:0001740 | Barr body(GO:0001740) |
0.5 | 0.5 | GO:0000791 | euchromatin(GO:0000791) |
0.5 | 11.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.5 | 1.5 | GO:0032009 | early phagosome(GO:0032009) |
0.5 | 1.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.5 | 4.6 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.5 | 2.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 6.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.5 | 2.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 3.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.5 | 4.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 1.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 4.8 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.5 | 2.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.5 | 3.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 1.9 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.5 | 2.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 1.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 4.6 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.5 | 4.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 0.9 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.5 | 3.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 8.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 2.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 1.3 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.4 | 2.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 3.4 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.4 | 2.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 1.2 | GO:0001652 | granular component(GO:0001652) |
0.4 | 1.6 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 6.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 2.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 3.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.4 | 2.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 2.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.4 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.4 | 3.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 1.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.4 | 3.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.4 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 2.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
0.4 | 4.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 2.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 11.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 1.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 1.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 10.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.4 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 4.2 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 3.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 1.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 1.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.3 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 2.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 1.0 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 16.8 | GO:0016605 | PML body(GO:0016605) |
0.3 | 1.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 1.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 3.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 13.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 1.6 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 14.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 4.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 11.9 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 0.3 | GO:0030684 | preribosome(GO:0030684) |
0.3 | 5.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 4.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.3 | 1.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.3 | 6.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 2.4 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.3 | 1.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 31.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 24.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 3.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 3.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 18.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 1.0 | GO:0001741 | XY body(GO:0001741) |
0.3 | 4.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 1.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 2.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 3.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 4.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 1.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 2.1 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 0.7 | GO:1902911 | protein kinase complex(GO:1902911) |
0.2 | 2.1 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.9 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 4.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 24.1 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 2.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 3.3 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 3.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 2.6 | GO:0005844 | polysome(GO:0005844) |
0.2 | 2.5 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 8.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 2.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 1.8 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 7.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 8.7 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.2 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.6 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.2 | 1.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 10.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 2.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 5.4 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.2 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.1 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.2 | 8.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 5.7 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 5.6 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.2 | 1.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.2 | 1.1 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 10.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 1.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 1.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 0.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 1.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 0.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.0 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 43.6 | GO:0005768 | endosome(GO:0005768) |
0.2 | 5.3 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 0.3 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.2 | 0.8 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 7.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 13.6 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 114.6 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 1.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.1 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.1 | 0.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.1 | GO:0030313 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
0.1 | 1.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 48.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 2.3 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 1.9 | GO:0034358 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 37.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 1.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.1 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 2.0 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 3.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 137.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.2 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 1.9 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 2.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 13.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 4.8 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 6.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.2 | GO:0031967 | organelle envelope(GO:0031967) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 6.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 2.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 5.9 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 227.0 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 39.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 9.9 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 2.7 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 0.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.8 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 6.0 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 12.6 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 3.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 21.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.6 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 172.3 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.3 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.1 | GO:1902494 | catalytic complex(GO:1902494) |
0.0 | 0.2 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.4 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 2.5 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.0 | GO:0005773 | vacuole(GO:0005773) |
0.0 | 0.1 | GO:0005819 | spindle(GO:0005819) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
2.9 | 8.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.5 | 7.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.4 | 11.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
2.3 | 9.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
2.2 | 6.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.0 | 23.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.6 | 4.8 | GO:0033691 | sialic acid binding(GO:0033691) |
1.6 | 4.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.6 | 4.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.5 | 15.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.5 | 35.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.5 | 4.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
1.5 | 10.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.4 | 4.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.3 | 8.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.3 | 3.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.2 | 11.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
1.2 | 3.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.2 | 7.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.2 | 4.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.1 | 4.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.1 | 15.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.1 | 6.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.0 | 2.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
1.0 | 4.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.9 | 1.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.9 | 4.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.9 | 2.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.9 | 6.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.8 | 2.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.8 | 13.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.8 | 1.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.8 | 7.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.8 | 2.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.8 | 10.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.8 | 6.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 2.4 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.8 | 4.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 3.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.8 | 2.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.8 | 8.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.8 | 2.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.8 | 5.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.7 | 4.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.7 | 13.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.7 | 2.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.7 | 5.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.7 | 2.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.7 | 2.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 17.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.7 | 2.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.7 | 2.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.6 | 2.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.6 | 1.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 10.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.6 | 23.4 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.6 | 8.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 1.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 30.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 3.1 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 18.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.6 | 3.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.6 | 2.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.6 | 1.9 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.6 | 1.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 3.7 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 1.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 3.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.6 | 2.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.6 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 1.8 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.6 | 1.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.6 | 1.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.6 | 1.7 | GO:0004875 | complement receptor activity(GO:0004875) |
0.6 | 7.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.5 | 1.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.5 | 19.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 2.7 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.5 | 7.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.5 | 1.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.5 | 2.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 1.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.5 | 1.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 0.5 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.5 | 3.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 2.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.5 | 3.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 1.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 2.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 0.5 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.5 | 3.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 2.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.5 | 1.5 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.5 | 6.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 1.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 2.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 2.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 2.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 1.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.5 | 2.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 1.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.5 | 1.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 1.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.5 | 2.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 2.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.5 | 6.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 5.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 3.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.5 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.5 | 7.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 1.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 3.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 2.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.5 | 5.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 0.4 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 1.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 4.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.4 | 4.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 23.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.3 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.4 | 1.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.4 | 2.2 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 6.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.4 | 3.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.4 | 3.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 1.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 3.9 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.4 | 3.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 2.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 3.0 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.4 | 2.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 1.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 3.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 0.8 | GO:0060229 | lipase activator activity(GO:0060229) |
0.4 | 1.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 4.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.4 | 14.8 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.4 | 1.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 2.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 2.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 2.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 1.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 7.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 2.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 3.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 2.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 6.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 0.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 1.5 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.4 | 0.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 4.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.4 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 1.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 17.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.4 | 3.9 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.4 | 1.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 1.1 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 1.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 11.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.4 | 7.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 1.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 1.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 2.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 2.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 2.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 8.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 2.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 4.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 3.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 2.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 1.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 2.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.3 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.3 | 3.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 2.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 1.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 5.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 1.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 3.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 7.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 0.9 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 1.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 1.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 8.2 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 0.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 0.3 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 0.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.3 | 2.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.3 | 0.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 2.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.3 | 4.2 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 2.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 4.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 0.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 0.9 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 4.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 0.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 0.9 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 3.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 2.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 0.9 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 0.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 6.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 2.6 | GO:0019864 | IgG binding(GO:0019864) |
0.3 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 4.9 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 3.4 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 0.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.3 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.3 | 1.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 0.8 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 1.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 1.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 1.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 0.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 1.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 0.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 0.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 7.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 7.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 0.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 2.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 6.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 1.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.2 | 4.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.7 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 1.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 4.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 10.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 0.9 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.2 | 20.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 1.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 4.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 0.7 | GO:0042287 | MHC protein binding(GO:0042287) |
0.2 | 1.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 6.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 3.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 1.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 5.3 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.9 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 0.6 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 5.8 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 1.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 1.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 7.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 0.8 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 1.5 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.6 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 15.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 4.6 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 1.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 4.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 4.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.6 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.2 | 2.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 3.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 1.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.6 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 7.3 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 1.6 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.2 | 0.5 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.2 | 1.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 7.0 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.2 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 102.3 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.2 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 0.7 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.2 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 2.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 4.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 1.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 2.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 0.8 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.2 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 3.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 0.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.3 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.2 | 5.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 1.4 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 1.0 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.2 | 0.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.8 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 0.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 2.0 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.2 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.6 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.2 | 4.6 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.2 | 28.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.6 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 1.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 1.9 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 1.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.8 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 41.2 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 3.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.6 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 1.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 3.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 40.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 1.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 1.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 2.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 3.6 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.4 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.5 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 1.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.7 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 2.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 1.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.3 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 2.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 3.4 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.9 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 7.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 2.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 182.1 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.2 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 3.2 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 1.9 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.1 | 0.3 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.6 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 7.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.4 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.3 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.6 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 5.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.6 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 1.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.3 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 4.5 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.8 | GO:0005035 | death receptor activity(GO:0005035) |
0.1 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 5.9 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.1 | GO:1901338 | dopamine binding(GO:0035240) catecholamine binding(GO:1901338) |
0.1 | 0.4 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 1.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.3 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.2 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.9 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 9.6 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 18.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 1.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.0 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 2.9 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 6.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 1.7 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 1.7 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.0 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.0 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.0 | 0.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 95.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.7 | 20.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.4 | 21.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.4 | 34.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.1 | 1.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.1 | 2.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.1 | 2.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.0 | 39.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.9 | 5.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 36.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.8 | 17.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 10.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 21.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 33.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.8 | 9.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.7 | 5.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.7 | 16.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 7.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 8.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.6 | 4.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 2.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 8.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.6 | 14.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 11.7 | PID MYC PATHWAY | C-MYC pathway |
0.6 | 12.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 15.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 8.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 3.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 3.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 6.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 5.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 4.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 15.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 2.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 3.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 4.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.4 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 2.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 1.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 5.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 2.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 11.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 4.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 3.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 12.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 9.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 2.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 2.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 1.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 7.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 3.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 4.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 8.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 5.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 3.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 2.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 3.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 3.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 1.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 2.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 0.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 2.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 2.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 2.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 6.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 6.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 6.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 2.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 3.1 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 4.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 6.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 2.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.0 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 2.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 2.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 19.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
2.3 | 7.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.1 | 31.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.1 | 28.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.4 | 31.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.1 | 16.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.1 | 2.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.1 | 17.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.1 | 14.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.0 | 24.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.9 | 20.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.9 | 13.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.9 | 19.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.9 | 18.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.9 | 0.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.9 | 6.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.8 | 2.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.8 | 10.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.8 | 3.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 10.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.7 | 7.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.7 | 8.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.7 | 2.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 5.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 2.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.7 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.7 | 5.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.6 | 3.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.6 | 10.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.6 | 7.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 18.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.6 | 3.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.6 | 2.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.6 | 0.6 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.6 | 27.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 4.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.5 | 1.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 6.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 6.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 8.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 16.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 2.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.5 | 3.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.5 | 8.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 9.6 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.5 | 7.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 4.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 1.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 1.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.4 | 5.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 4.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.4 | 4.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 1.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 3.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 9.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 7.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 1.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 0.4 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.4 | 5.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 3.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 22.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 3.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 4.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 5.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 5.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 4.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 4.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 10.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 8.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 4.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 3.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 3.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 2.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 6.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 0.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.3 | 4.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 6.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 0.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 6.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 3.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 7.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 3.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 1.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 12.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 2.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.3 | 4.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 1.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 0.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.3 | 3.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 7.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 19.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 1.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 1.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 15.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 8.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 0.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 0.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 3.6 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.2 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 0.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 1.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 15.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 0.6 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 3.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 1.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 2.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 4.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 7.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 2.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 1.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 10.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 21.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 5.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 0.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 3.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 1.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 5.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 2.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 0.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 1.3 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.2 | 8.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 2.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 3.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 1.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 2.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 7.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 13.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 6.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 3.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 2.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.1 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 1.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 3.3 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.2 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 3.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 5.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 4.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.7 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 15.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 3.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 5.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.4 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 1.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 16.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 2.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 1.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |